Long noncoding RNA (lncRNA) is a leader of the degree of more than 200 nucleotides, almost do not have the function of protein coding endogenous RNA molecules. Recent studies show that, lncRNA is not encoded protein, but it has a wide range of biological functions, and lncRNA in human diseases, especially in oncology, more and more attention has been paid to its role. Nasopharyngeal carcinoma (NPC) is a common malignant tumor of the head and neck in South China, which poses a serious threat to people's health and life. Studies found that lncRNA is widely involved in the invasion, metastasis and prognosis of nasopharyngeal carcinoma (NPC). In this article, we will review the research progress of lncRNA in nasopharyngeal carcinoma.
Introduction
Nasopharyngeal carcinoma is one of common head and neck malignant tumors in China, which is a kind of malignant tumor which occurs in the nasopharyngeal epithelium. It has obvious geographic differences, the highest rates in southern China's Guangdong area, therefore, nasopharyngeal carcinoma also known as "Guangdong carcinoma" [1] . Because of nasopharyngeal carcinoma is mainly located at the top and lateral wall of nasopharynx, relatively hidden, when the early onset of symptoms is not obvious, or lack of specificity, and is easy to be ignored by the patients. And the vast majority of poorly differentiated nasopharyngeal carcinoma, malignant degree is high, easy early cervical lymph node and distant metastases, most patients were advanced nasopharyngeal car-cinoma on symptoms or when they see a doctor [2] . Nasopharyngeal carcinoma is generally sensitive to radiotherapy. Although with the development of medical imaging technology progress, at present the main approaches of radiotherapy for nasopharyngeal carcinoma, greatly improve the local control of nasopharyngeal carcinoma and 5 years survival rate, but frequent tumor recurrence and poor prognosis for clinical is still a great challenge [3] . The etiology of nasopharyngeal carcinoma is still unknown, and many years of research at home and abroad confirmed that nasopharyngeal carcinoma may be related to EB virus infection, environmental chemical carcinogens (such as nitrosamines) and genetic factors [4] . But what is certain is that the development of nasopharyngeal carcinoma is the development of the many factors, many steps, and multiple genes involved in the result. However, gene expression changes in which plays a vital role. Studies have shown that in recent years [5] [6] [7] [8] [9] , the abnormal expression of lncRNA in many tumors is closely related to the proliferation, differentiation and migration of tumor cells. So the lncRNA differentially expressed in nasopharyngeal carcinoma and its potential regulation and control mechanism for the diagnosis, treatment and prognosis of nasopharyngeal carcinoma has extremely important clinical application value [10] .
Biological Characteristics of lncRNA
Long non-coding RNA (lncRNA) is transcribed by RNA polymerase II, with a transcription length greater than 200 nucleotides, similar in structure to mRNA. lncRNA does not have an obvious open reading frame and does not participate in or is rarely involved in coding proteins. However, lncRNA is a class of endogenous RNA that regulates the expression of genes. It is located in the nucleus or cytoplasm, and its expression is tissue-specific and spatiotemporal [11] [12] . In comparison with other noncoding RNA, lncRNA has "more than and 3" characteristics, namely multi type, multi number and mode of action [13] [14] .
LncRNA was first discovered in 2002, Okazaki et al. [15] found a new transcript of DNA (complementary DNA) on a large scale sequencing in mice, namely lncRNA. However, lncRNA has been regarded as the "noise" of gene transcription since it was discovered, and it is a by-product of Pol II transcription [16] , and for a long time, researchers have not paid enough attention to it. Later, with the in-depth study, more and more evidence indicates that as a kind of important biological macromolecules, lncRNAs is involved in many biological processes [17] . Although lncRNA does not encode proteins, it has high tissue specificity, which can regulate gene expression from epigenetic, transcriptional and post transcriptional levels [18] Mercer et al. [26] can be divided into cis regulatory lncRNA and trans regulation lncRNA [28] .
According to the molecular mechanism of, it can be divided into signal molecules, decoy molecules, scaffold molecules, and molecules [29] .
The Mode of Action and Regulation Mechanism of lncRNA
LncRNA regulates gene expression in a variety of ways and mechanisms, can be divided into the following categories:
Chromatin Remodeling
DNA replication, transcription, repair and recombination are both occurred at the chromatin level. In these processes, chromatin remodeling can lead to changes in the position and structure of nucleosomes, resulting in chromatin changes. Chromatin state, however, is a key factor in transcriptional activity, including changes in nucleosome structure and covalent modifications of histones. [30] studies have shown that over expression of HOTAIR can cause the PRC2 complex to be repositioned in the whole genome, which makes some tumor suppressor genes silenced, thereby promoting the metastasis of cancer cells.
Transcriptional Regulation
Transcription regulation is by changing rate can change the level of gene expres-sion. LncRNA can be regulated by a variety of mechanisms, including gene silencing, DNA damage activation, post transcriptional regulation and so on.
Precursor mRNA Splicing Regulation
Precursors shear refers to the process of removing unnecessary sequences of mRNA precursors in the nucleus and connecting the various parts of the shear.
Studies found that long non-coding RNA-lung adenocarcinoma metastasis associated transcript 1 (MALAT1) plays a key role in the processing of mRNA precursors, and has a broad impact on human health.
LncRNA Related Databases
With the increasing attention to the lncRNA gene and the deepening of related research, more and more new lncRNA have been found. Databases that collect, organize and classify information about lncRNA genes are being taken seriously by researchers. In recent years, researchers have established several lncRNA related databases by combining bioinformatics techniques (Table 1) [31]- [39] . The establishment of these databases not only provides researchers with comprehensive information about lncRNA of various species, but also provides a very important platform for the study of the regulatory relationship between lncRNA and nasopharyngeal carcinoma.
The Research Status of lncRNA Associated with Nasopharyngeal Carcinoma
The following is the current studies have found lncRNA are closely associated with nasopharyngeal carcinoma (Table 2 ).
H19
H19 gene is the first tumor related lncRNA was found, which is located on human chromosome 11p15.5, length of 2 -3 kb, a total of 5 exons and 4 introns, is one of the earliest identification of imprinted genes. It shows the characteristics lncRNA-ROR Tissue, cell Invasion, metastasis, chemotherapy-resistant Up-regulation [51] of paternally imprinted, selective expression of the maternal allele, the differentially methylated region is mainly affected by the upstream 4000 bp rich CpG island methylation regulation (DMR). H19 can regulate the growth and development of the embryo, but the expression of H19 is inhibited in the majority of tissues and organs after birth. H19 is mainly present in the cytoplasm and regulates gene expression in a regulated RNA or ribose regulator, and its first exon can encode miR-675. In recent years, studies have found that H19 in nasopharyngeal carcinoma in the presence of abnormal expression. Ng et al. [40] , by using gene chip and Northen hybridization technology to determine the gene that is up-regulated in undifferentiated human nasopharyngeal carcinoma cell line CNE-2 is the human imprinted gene lncRNA-H19. However, H19 was down regulated in a well differentiated human nasopharyngeal carcinoma cell line HK1. The study also found that the low expression of H19 HK1 in the promoter region of H19 gene CpG locus (i.e. cytosine phospho guanine sites) showed a high degree of methylation, leading to transcriptional silencing, which lead to the low expression of H19 gene. And the expression of H19 was up-regulated by demethylation of HK1 cells. It is suggested that the methylation of the promoter region of the H19 gene may play an important role in the differentiation of human nasopharyngeal carcinoma cells and the transcription process of the imprinted gene. Zhang et al. [41] study found that the expression level of H19 in metastatic nasopharyngeal carcinoma tissues was higher than that in primary NPC tissues, the former was 1.8 -3.0 times higher than that of the latter. Therefore, studies have shown that lncRNA H19 can promote the invasion and metastasis of nasopharyngeal carcinoma. The study also shows that HOX transcribed antisense RNA may become a biological marker of nasopharyngeal carcinoma prognosis and survival test, and thus play an important role in the diagnosis and treatment of nasopharyngeal carcinoma.
HOTAIR
HOTAIR
LOC401317
P53 gene is one of the earliest tumor suppressor genes (or tumor suppressor genes), it can regulate a series of signal transduction pathways and thus widely involved in the development of a variety of malignant tumors. A large number of studies have confirmed that p53 protein can regulate cell cycle and avoid cell carcinogenesis. Cong et al. [45] showed that 133 LncRNAs were up-regulated and 1057 lncRNAs were down-regulated by transgenic Pcmv-p53 vector expressing p53 gene into nasopharyngeal carcinoma cell line HNE2 by gene chip technique, while lncRNA LOC401317 Significantly elevated expression. It was also found that LOC401317 was directly regulated by p53 and inhibited the growth of CNE2 cells by blocking cell cycle G1/S and induced apoptosis, suggesting that LOC401317 could play an anti-tumor effect in nasopharyngeal carcinoma.
MALAT1
MALAT1, a lung adenocarcinoma metastasis-related transcript 1, located at 11q13.1, is a long chain non-coding RNA with a transcript length of more than 8000 nucleotides. MALATI was first discovered by scientists in the study of genes related to the metastasis of human non-small cell lung cancer. A large number of studies have found that MALAT1 in a variety of malignant tumors (such as lung cancer, colon cancer, pancreatic cancer, etc.) and the high expression of its survival rate was significantly correlated. The study also found that MALAT1 mainly through the regulation of apoptosis, regulation of cell cycle and affect cell epithelial mesenchymal transition, thus affecting the development of malignant tumors. Xie et al. [46] found that MALAT1 gene was highly expressed in high metastatic nasopharyngeal carcinoma cell lines and was low in normal nasopharyngeal epithelium using Real-time PCR. The expression of E-cadherin in CNE-1 cells was significantly down-regulated by MALAT1 overexpression in CNE-1 cells after transfection of CNE-1 cells by lentiviral vector.
The expression of interstitial cell markers (E-cadherin) Vimentin) expression was significantly increased, the ability to invasion and metastasis was significantly enhanced, suggesting that MALAT1 can promote the invasion and metastasis of nasopharyngeal carcinoma. Jin et al. [47] have shown that MALAT1 is significantly up-regulated in nasopharyngeal carcinoma, and that MALAT1 gene can make nasopharyngeal carcinoma cells more sensitive to radiotherapy.
MALAT1 can also be regulated by adjusting miR-1/slug axis Tumor stem cell activity and radioactivity resistance, suggesting that MALAT1 may be a therapeutic target for patients with nasopharyngeal carcinoma.
LncRNA-LET
LncRNA-LET (lncRNA Low Expression in Tumor) is a newly identified long- anti-tumor effect of the specific needs of more studies confirmed that through the LET on nasopharyngeal carcinoma cell therapy has yet to be further studied.
LncRNA AFAP-AS1
BO et al. [50] 
LncRNA-ROR
LncRNA-ROR is a newly identified lncRNA. Li et al. [51] found that LncRNA-ROR overexpression in human nasopharyngeal carcinoma and nasopharyngeal carcinoma cell lines and found that lncRNA-ROR expression levels were detected by RT-PCR The expression of lncRNA-ROR in nasopharyngeal carcinoma (CNE2, CNE1, 5-8F, 6-10B) was also higher than that in normal nasopharyngeal epithelium NP69 high. Study further demonstrated that lncRNA-ROR by regulating the cell cycle and promote the proliferation of nasopharyngeal carcinoma cells by affecting the epithelial mesenchymal transition and promote cell migration and invasion of nasopharyngeal carcinoma, the study discovers the lncRNA-ROR through the P53 pathway to produce chemotherapy resistance in nasopharyngeal carcinoma cells.
Summary and Prospect
To sum up, lncRNA, as a gene that can directly affect cell signal transduction which is also the lncRNA need to be solved in the research of nasopharyngeal carcinoma.
